Press Release: ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

[fa icon="calendar'] Oct 10, 2018 6:35:50 AM / by Simon Padbury posted in Press Release, Research & Development, iPSCs, Stem Cells, Clinical Grade

[fa icon="comment"] 0 Comments

Funding will be used to improve efficiency of induced pluripotent stem cell production

Location: REPROCELL Europe Ltd. (Glasgow, UK) and  RosslinCT (Edinburgh, UK)
Date: October 10, 2018
Continue reading [fa icon="long-arrow-right"]

From Frying-Pan to Fire

[fa icon="calendar'] Sep 13, 2018 7:54:45 AM / by Zara Puckrin posted in Research & Development, Government Partnership, Internship

[fa icon="comment"] 0 Comments

How can industry inspire the next generation of life science professionals?  Summer intern Zara Puckrin describes the challenges faced by today’s graduates and explains how REPROCELL have helped her to bridge the gap between university and work.

Continue reading [fa icon="long-arrow-right"]

REPROCELL’s David Bunton addresses the Scottish Parliament

[fa icon="calendar'] Mar 21, 2018 11:58:30 AM / by Abbie Wishart posted in Drug Discovery, Government Partnership, Scotland's Economic Performance, Research & Development, SME

[fa icon="comment"] 0 Comments

On Tuesday 20th March 2018 REPROCELL Europe Ltd’s CEO Dr David Bunton appeared in front of the Economy, Jobs and Fair Work Committee at the Scottish Parliament to discuss Scotland’s Economic performance.  He was also joined by:

• Dr Diane Harbison, CEO, of Stratified Medicine Scotland

• Claire Mack, CEO, of Scottish Renewables

• Gareth Wynn, Stakeholder and Communications Director, Oil & Gas UK

Continue reading [fa icon="long-arrow-right"]